Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF ACCRUED EXPENSES (Details)

v3.22.0.1
SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Accrued clinical operations and trials costs $ 5,435,464 $ 14,132,842
Accrued product development costs 203,676 2,189,047
Accrued compensation 2,715,368 4,222,594
Accrued other 1,738,804 1,460,949
Total $ 10,093,312 $ 22,005,432